Summary

Report Scope:

This report examines the current and forecasted market potential of radiopharmaceuticals and therapeutics. It offers a detailed analysis of the technological advancement, competitive environment, market background, drivers and restraints, and market growth trends. The research report also includes market projections to 2026. The scope of this report is broad and covers type, production method, technology and applications of radiopharmaceuticals and therapeutics. By type, the market has been segmented into radiotherapy and radiopharmaceuticals. Revenue forecasts from 2021 to 2026 are provided for each segment and regional market, with estimated values derived from manufacturers’ total revenues.

The report also includes a discussion of the major market players in radiopharmaceuticals and therapeutics. Further, it explains the major drivers and regional dynamics of the global radiopharmaceutical and therapeutics market and current trends within the industry.

By geography, the radiopharmaceutical and therapeutics market has been segmented into Europe, North America, Asia-Pacific (APAC) and the Rest of the World (RoW). The detailed analyses of major countries such as the U.S., Germany, Canada, the U.K., Spain, France, Japan, India and China are covered in regional segments. For market estimates, data is provided for 2020 as the base year, 2021 and forecast through year-end 2026. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.

Report Includes:

- 52 data tables and 72 additional tables
- An overview of the global market for radiotherapy, radiopharmaceuticals, and nuclear medicines
- Estimation of the market size and analyses of the global market trends, with data from 2019 to 2020, estimates for 2021, with projection of CAGR through 2026
- Analysis of new opportunities, challenges, and technological changes within the industry and highlights of the market potential by type, method, technology, application and region
- Assessment of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
- Description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
- Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
- Detailed analysis of the current market trends and forecast, relevant R&D activities, new products launches and product enhancement in the industry and discussion of regulatory elements that are affecting the future marketplace
- Market share analysis of the key companies of the industry and coverage of events like mergers & acquisitions, joint ventures, collaborations or partnerships, and other key market strategies
- Company profiles of major players in the market, including Accuray Inc., Bayer Pharma AG, Cardinal Health, General Electric Co., Nordion Inc. and Siemens Healthineers AG

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
What's New in This Report?
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter 2 Summary and Highlights
Highlights of the Market for Radiopharmaceuticals and Therapeutics
Chapter 3 Regulatory Scenario
Regulatory Outlook
United States
Canada
Australia
India
European Union
Chapter 4 Radiopharmaceuticals and Therapeutics: Background
Introduction
Uses of Radiopharmaceuticals
Evolution and Transition of Radiopharmaceuticals
Radiotherapy
Ionizing Radiation
Non-ionizing Radiation
Evolution and Transition of Radiation Therapy
The Discovery Period: 1890s
Kilovoltage Era: 1900-1940
Megavoltage Era: 1946-1996
Computer-Assisted Era: 1996-Present
Market Potential
Investment Analysis
Radiotherapy Subsegments
Radiotherapy Subsegments by Type
Radiopharmaceuticals Subsegments by Type
Production Method Subsegments
Technology Subsegments
Radiopharmaceuticals and Therapeutics, by Application
Chapter 5 Market Dynamics
Trends
Respiratory Gating
Proton Therapy
Carbon Ions
Magnetic Resonance-Driven Linear Accelerator
Drivers
Increasing Aging Population
Increasing Incidence of Life-Threatening Diseases
Increasing Incidence of Cancer
High Incidence of Cancer in Aging Population
Growing Healthcare Spending in Emerging Regions
Advancements in Technology
Growing Focus on Early Diagnosis and Treatment
Increasing Number of Cyclotrons
Increasing Amount of Nuclear Imaging Equipment
High Efficiency of Radiotherapy
Palliative Radiation Therapy
Restraints and Challenges
Limited Global Supply of Medical Isotopes
Reimbursement Policies
Regulatory Issues
Expensive Equipment
Lack of Trained Professionals
Limited Effectiveness against Metastatic Cancer
Side Effects of Radiation Therapy
Opportunities
Developing Countries
Replacement of Old Equipment
Chapter 6 Impact of COVID-19 Pandemic
Introduction
Impact of COVID-19 on Radiopharmaceuticals and Therapeutics
Impact on Cancer Research
Public Health Impact of COVID-19 Across the Cancer Continuum
Chapter 7 Market Breakdown by Type
Radiotherapy
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiotherapy
Radiopharmaceuticals
Diagnostics
Therapeutics
Chapter 8 Market Breakdown by Production Method
Particle Accelerators (Cyclotrons)
Particle Accelerator Process
Nuclear Reactors
Radionuclide Generators
Production of Radioisotopes Through Radionuclides
Chapter 9 Market Breakdown by Technology
External Radiotherapy by Technology
Particle Therapy/Proton Beam Therapy
Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
Image-Guided Radiation Therapy (IGRT)
Intensity-Modulated Radiation Therapy (IMRT)
Tomotherapy
Three-Dimensional Conformal Radiation Therapy (3D-CRT)
Volumetric Modulated Arc Therapy (VMAT)
Internal Radiotherapy by Technology
Pulsed-Dose-Rate (PDR) Brachytherapy
Low-Dose-Rate Brachytherapy
High-Dose-Rate (HDR) Brachytherapy
Systemic Radiotherapy by Technology
Comparison between Alpha and Beta Emitters
Chapter 10 Market Breakdown by Application
External Beam Radiation Therapy
Treatment Planning for External Beam Radiation
Dosing and Treatment with External Beam Radiation
Electron-Emitting High-Energy Linear Accelerators (LINACs)
Internal Radiation Therapy
Applications of Internal Beam Radiation Therapy
Systemic Radiation Therapy
Applications of Systemic Radiation Therapy
Chapter 11 Market Breakdown by Region
North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Rest of the World (RoW)
Chapter 12 Patent Analysis
U.S. Patent Analysis
European Patent Analysis
Japanese Patent Analysis
Chapter 13 Competitive Landscape
Global Company Share Analysis
Mergers and Acquisitions
Agreements, Collaborations, Product Launches and Partnerships
Chapter 14 Company Profiles
ACCURAY INC.
ADVANCED ACCELERATOR APPLICATIONS SA (NOVARTIS)
ALLIANCE MEDICAL GROUP
BAYER PHARMA AG
BECTON, DICKINSON AND CO. (BD)
BRACCO DIAGNOSTIC INC.
CARDINAL HEALTH
COQUI RADIOPHARMACEUTICALS CORP.
CURIUM
ECKERT & ZIEGLER BEBIG
ELEKTA
FUJIFILM HOLDINGS CORP.
GENERAL ELECTRIC CO.
ISO-TEX DIAGNOSTICS INC.
JUBILANT DRAXIMAGE INC.
LANTHEUS MEDICAL IMAGING INC.
NATIONAL CENTRE FOR NUCLEAR RESEARCH POLATOM
NATIONAL INSTITUTE FOR RADIOELEMENTS (IRE)
NORDION INC.
NTP RADIOISOTOPES SOC LTD.
PHARMALUCENCE INC.
PMB ALCEN
SIEMENS HEALTHCARE
VIVOS INC.